S&P 및 Nasdaq 내재가치 문의하기

Alvotech ALVOW NASDAQ

NASDAQ Global Market • Healthcare • Drug Manufacturers - Specialty & Generic • IS • USD

SharesGrow Score
57/100
2/6 Pass
SharesGrow Intrinsic Value
$76.24
+27128.6%

Alvotech (ALVOW) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.

애널리스트 추정 주당순이익(EPS) $-0.13 및 매출 $0.45B 다음 회계연도.

주당순이익(EPS) 실적 추이: 2024: 실적 $-0.87 vs 추정 $-0.13 (하회 -593.3%). 2025: 실적 $0.10 vs 추정 $-0.08 (상회 +223.1%). 애널리스트 정확도: 0%.

EPS 전망 — ALVOW

0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024 Actual –$0.87 vs Est –$0.13 ▼ 85.6% off
2025 Actual $0.10 vs Est –$0.08 ▲ 181.2% off
Profitability Outlook
Company has mixed profitability — some years profitable, some at a loss. EPS trend is improving.

매출 전망 — ALVOW

96%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual $0.490B vs Est $0.454B ▲ 7.2% off
2025 Actual $0.586B vs Est $0.581B ▲ 0.9% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
문의하기
🎓
SharesGrow 아카데미
내재가치 계산법과 저평가 종목 찾기를 배우세요.
주간 라이브 세션
메시지 보내기